Figure 1. BCL2A1 was overexpressed in gliomas. (A) The expression of BCL2A1 in 33 human cancers and normal tissues in TCGA and GTEx databases. (B) The expression of BCL2A1 in different types of cancers in Oncomine. (C) The mRNA expression of BCL2A1 in gliomas and NBTs in public datasets. (D, E) IHC staining analysis of BCL2A1 in glioma NBTs in an in-house cohort. *P < 0.05, **P < 0.01. ***P < 0.001, ****P < 0.0001. Abbreviations: IHC: immunohistochemistry; NBTs: normal brain tissues.